Skip to search formSkip to main contentSkip to account menu

trisuccin

Known as: N-(tris(2-((N-(benzyloxy)amino)carbonyl)ethyl)methyl)succinamic acid 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Hydroxamic AcidsSuccinates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Biodistribution Study of 188 ReLabeled Trisuccin-HuCC 49 and Trisuccin-HuCC 49 ACa 2 Conjugates in Athymic Nude Mice Bearing Intraperitoneal Colon Cancer Xenografts
  • 2007
  • Corpus ID: 12189706
The t r ihydroxamate bifunctional chelating agent (BCA), trisuccin, has been shown to be a potential ligand for radiolabeling of… 
1999
1999
Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
The trihydroxamate bifunctional chelating agent (BCA), trisuccin, has been shown to be a potential ligand for radiolabeling of… 
1997
1997
Conjugation of unprotected trisuccin, N-[tris[2-[(N-hydroxyamino)carbonyl]ethyl]methyl]succinamic acid, to monoclonal antibody CC49 by an improved active ester protocol.
For the conjugation of the trihydroxamate bifunctional chelating agent N-[tris[2-[[N-(benzyloxy)amino]-carbonyl]ethyl]methyl… 
1997
1997
Synthesis, rhenium-188 labeling and biodistribution studies of a phenolic ester derivative of trisuccin
Our previous results indicated that the trihydroxamate ligand, trisuccin, was a promising bifunctional chelating agent (BCA) for… 
1994
1994
Rhenium-186 labeling of CC49 monoclonal antibody with N-[TRIS[2-[[N-(benzyloxy) amino] carbonyl]-ethyl]methyl] succinamic acid, trisuccin and biodistribution studies
The use of hydroxamic acid derivatives as bifunctional chelating agents (BCAs) for radiolabeling of monoclonal antibodies, and… 
1993
1993
Synthesis of N-[tris[2-[[N-(benzyloxy)amino]carbonyl]ethyl]methyl]succinamic acid, trisuccin. Hydroxamic acid derivatives as a new class of bifunctional chelating agents.
In an effort to generate bifunctional chelating agents (BCAs) with improved labeling, conjugation, and biodistribution properties… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)